✦ LIBER ✦

Epoprostenol treatment of acute pulmonary hypertension is associated with a

✍ Scribed by Steffen Rex; Carlo Missant; Patrick Segers; Rolf Rossaint; Patrick F. Wouters

Publisher: Springer
Year: 2007
Tongue: English
Weight: 328 KB
Volume: 34
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-007-0831-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of non-cardiogenic acute pulmonar

A case of non-cardiogenic acute pulmonary edema in a patient with POEMS syndrome-associated pulmonary arterial hypertension

✍ Masahiko Hara; Isamu Mizote; Yoshikazu Nakaoka; Hirokazu Tanaka; Yoshihiro Asano 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 70 KB

Relative systemic hypertension in patien

Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency

✍ Victor R. Gordeuk; Vandana Sachdev; James G. Taylor; Mark T. Gladwin; Gregory Ka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Improvement in pulmonary hemodynamics du

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension

✍ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope

Prevalence of pulmonary hypertension ass

Prevalence of pulmonary hypertension associated with severe acute respiratory distress syndrome: Predictive value of computed tomography

✍ Martin Beiderlinden; Hilmar Kuehl; Tanja Boes; Jürgen Peters 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 131 KB

Pulmonary edema complicating prostacycli

Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: A case of pulmonary capillary hemangiomatosis

✍ Manish K. Gugnani; Chris Pierson; Richard Vanderheide; Reda E. Girgis 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Continuous intravenous infusion of prostacyclin is an effective treatment for primary pulmonary hypertension (PPH), and has recently been shown to be of benefit in PH associated with scleroderma (SSc). Pulmonary capillary hemangiomatosis (PCH) is a rare cause of PPH. Prostacyclin therapy has been co

Echocardiographic Evidence of Pulmonary

Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease

✍ Andrew C. Stone; Jason T. Machan; Jeffery Mazer; Brian Casserly; James R. Klinge 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 249 KB